(Q34294809)

1 August 2017

1 reference

title

Cytomegalovirus infection and cardiac allograft vasculopathy (English)

1 reference

1 August 2017

0 references

cytomegaloviral disease

1 reference

Koskinen PK

1

1 reference

1 August 2017

Kallio EA

2

1 reference

1 August 2017

Tikkanen JM

3

1 reference

1 August 2017

Sihvola RK

4

1 reference

1 August 2017

Häyry PJ

5

1 reference

1 August 2017

Lemström KB

6

1 reference

1 August 2017

publication date

1 June 1999

1 reference

Transplant Infectious Disease

1 August 2017

published in

1 reference

1 August 2017

volume

1

1 reference

1 August 2017

issue

2

1 reference

1 August 2017

page(s)

115-126

1 reference

Infection in organ-transplant recipients

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Increased Pulmonary Superinfections in Cardiac-Transplant Patients Undergoing Primary Cytomegalovirus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Infections Due to Herpesviruses in Cardiac Transplant Recipients: Role of the Donor Heart and Immunosuppressive Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Cytomegalovirus mononucleosis in a healthy adult: association with hepatitis, secondary Epstein-Barr Virus antibody response and immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl)guanine in patients with AIDS and other immunodeficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Isolation of a new herpesvirus from human CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Virus Infection of Endothelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Cytomegalovirus infection and viral-induced transformation of human endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Cytomegalovirus infection induces vascular injury in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Human cytomegalovirus penetrates host cells by pH-independent fusion at the cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Beta 2 microglobulin enhances the infectivity of cytomegalovirus and when bound to the virus enables class I HLA molecules to be used as a virus receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Cytomegalovirus - its cellular immunology and biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Studies on rat cytomegalovirus induced structural and non-structural proteins present at (immediate-)early and late times of infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

B cell activation by cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Immunologic abnormalities induced by postperfusion cytomegalovirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Virus infection of endothelial cells increases granulocyte adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Modulation of interleukin 1 beta gene expression by the immediate early genes of human cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Cytomegalovirus immediate early genes prevent the inhibitory effect of cyclosporin A on interleukin 2 gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Cytomegalovirus induction of tumor necrosis factor-alpha by human monocytes and mucosal macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Increased susceptibility to cytomegalovirus infection in beige mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

The cytolytic T lymphocyte response to the murine cytomegalovirus. II. Detection of virus replication stage-specific antigens by separate populations of in vivo active cytolytic T lymphocyte precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Tumour necrosis factor- production during cytomegalovirus infection in immunosuppressed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Virus-induced atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Viruses in the etiology of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Cytomegalovirus antigen within human arterial smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Cytomegalovirus causes a latent infection in undifferentiated cells and is activated by induction of cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Cytomegalovirus Replicates in Differentiated But Not in Undifferentiated Human Embryonal Carcinoma Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Pathogenesis of of cytomegalovirus infection. I. Activation of virus from bone marrow-derived lymphocytes by in vitro allogenic reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Cytomegalovirus infection-enhanced chronic kidney allograft rejection is linked with intercellular adhesion molecule-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Cytomegalovirus infection enhances experimental obliterative bronchiolitis in rat tracheal allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infections with organ involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

The pathogenesis of atherosclerosis: a perspective for the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine [(S)-HPMPC] and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Membrane guanylate cyclase is a cell-surface receptor with homology to protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Immunosuppressive effects of ganciclovir on in vitro lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Activity of 9-(1,3-dihydroxy-2-propoxymethyl)guanine compared with that of acyclovir against human, monkey, and rodent cytomegaloviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

Morbidity of cytomegalovirus infection in recipients of heart or heart-lung transplants who received cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

7 January 2021

Replication of cytomegalovirus in human arterial smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

7 January 2021

Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

7 January 2021

Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

7 January 2021

CD13 (human aminopeptidase N) mediates human cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

7 January 2021

Biology of rat cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

7 January 2021

An animal model for therapeutic intervention studies of CMV infection in the immunocompromised host

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

7 January 2021

Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

7 January 2021

HLA-Restricted Cytotoxic T Lymphocytes Are an Early Immune Response and Important Defense Mechanism in Cytomegalovirus Infections

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

7 January 2021

Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR beta chain: a means for graft rejection and immunosuppression

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

7 January 2021

The immediate early genes of human cytomegalovirus upregulate expression of the interleukin-2 and interleukin-2 receptor genes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

7 January 2021

Genetic selection, general characterization, and histology of atherosclerosis-susceptible and -resistant Japanese quail

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

7 January 2021

Herpesviridae in the endothelial and smooth muscle cells of the proximal aorta in arteriosclerotic patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

7 January 2021

Possible role of cytomegalovirus in atherogenesis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

7 January 2021

Potential role of human cytomegalovirus and p53 interaction in coronary restenosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

7 January 2021

CMV infection, class II antigen expression, and human kidney allograft rejection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

7 January 2021

Human cytomegalovirus ie1 transactivates the alpha promoter-enhancer via an 18-base-pair repeat element.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

7 January 2021

Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

7 January 2021

Risk factors for cytomegalovirus infection after human marrow transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

7 January 2021

The transfer of cytomegalovirus infection in rats by latently infected renal allografts, and the role of various immunosuppressive regimens in virus reactivation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

7 January 2021

Cytomegalovirus infection-enhanced allograft arteriosclerosis is prevented by DHPG prophylaxis in the rat

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

7 January 2021

Cytomegalovirus-induced regulation of major histocompatibility complex class I antigen expression in human aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

7 January 2021

Cytomegalovirus infection enhances mRNA expression of platelet-derived growth factor-BB and transforming growth factor-beta 1 in rat aortic allografts. Possible mechanism for cytomegalovirus-enhanced graft arteriosclerosis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

7 January 2021

Production of Platelet-Derived Growth Factor–like Mitogen by Smooth-Muscle Cells from Human Atheroma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

7 January 2021

TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

7 January 2021

Localization of PDGF-B protein in macrophages in all phases of atherogenesis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

7 January 2021

Regulation of differentiated properties and proliferation of arterial smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

7 January 2021

Expression and localization of platelet-derived growth factor ligand and receptor protein during acute and chronic rejection of rat cardiac allografts

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

7 January 2021

In vitro induction of endothelial HLA class II antigen expression by cytomegalovirus-activated CD4+ T cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

7 January 2021

The association of the induction of vascular cell adhesion molecule-1 with cytomegalovirus antigenemia in human heart allografts

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

7 January 2021

Cytomegalovirus infection-enhanced cardiac allograft vasculopathy is abolished by DHPG prophylaxis in the rat

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010205.X

7 January 2021

10.1034/J.1399-3062.1999.010205.X

Identifiers

DOI

1 reference

1 August 2017

1 reference